Abstract
THE significance of the common cold in industry and the incapacity and loss of time that result require no emphasis. It is estimated that millions of man-days of work are lost each year as the result of upper respiratory tract infections. It seems likely that the filterable virus is the primary causative agent, and that secondary symptoms are due to bacterial infection. It was felt, as a result of reports appearing in the American medical press and in view of the shortage of labour in 1944–45, that it would be useful to attempt to immunize against secondary organisms by the use of an oral vaccine.
Similar content being viewed by others
Article PDF
References
Rockwell, et al., J. Lab. Clin. Med., 22, 912 (1937).
Joiner, H., J. Med. Assoc. Georgia, 38, 332 (1939).
Stafford, C. I., Journal-Lancet, 60, 319 (1940).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
BOURNE, L. Trial of an Oral Vaccine against Bacterial Infection Accompanying the Common Cold. Nature 157, 591 (1946). https://doi.org/10.1038/157591b0
Issue Date:
DOI: https://doi.org/10.1038/157591b0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.